Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...

Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...

Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate ...

The researchers studied 62,839 people diagnosed with non-metastatic prostate cancer in Sweden between the years 2000-2020. All were placed within a defined risk category, had a life expectancy of more ...

Prostate cancer is one of the most common cancers in men, but when caught early, it's highly treatable. For Vernon Owens, a ...

The Gleason score is a grading system used by doctors to evaluate prostate cancer based on how the cancer cells look under a microscope. When a biopsy is done, small tissue samples are taken from ...

Former U.S. President Joe Biden’s recent cancer diagnosis brought widespread attention to what is known as the “Gleason score,” a grading system used to assess the prognosis of men with prostate ...

Understanding the Gleason Score The Gleason score is the histopathologic grading system for assessing the architectural patterns of prostate cancer cells in biopsies.

The Grade Group is the most common system doctors use to grade prostate cancer. It has replaced the Gleason score. The grade of a cancer tells you how much the cancer cells look like normal cells.